Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
0.5 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
6
Lobbying Costs over the years
-
Info
The Alliance for Safe Online Pharmacy in the EU (ASOP EU)
EU Transparency Register
273334013697-74 First registered on 27 May 2014
Goals / Remit
The Alliance for Safe Online Pharmacy in the EU (ASOP EU: www.asop.eu) is united by a single objective; that by taking concerted voluntary actions, and campaigning for appropriate legislation, a safer environment for patients who choose to buy their medicines online can be created. ASOP EU comprises a number of supporters, members and observers including representatives from consumer, healthcare and patient groups, shippers, branded and generic pharmaceutical manufacturers, pharmacy stakeholders, wholesalers, traders, advertising networks, internet advertising and search companies and market places, law enforcement and regulatory bodies. Similar organisations also exist in the United States, in particular the Alliance for Safe Online Pharmacies - Global (ASOP: http://buysaferx.pharmacy).
ASOP EU is actively involved with all global actors and seeks to cooperate closely with Europol, Interpol, EUIPO, OECD and the Council of Europe allied with the Medicrime Convention activitiesMain EU files targeted
Campaigning to ensure that implementation of the Falsified Medicines Directive continues to be successful, particularly the implementation of the safety features in the hospital sector which became mandatory on February 9th 2019 as well as the Common Logo. These will be achieved by raising public awareness through educational campaigns as well as EU Parliament roundtables. And also by collaboration with appropriate government medical regulatory bodies. Close liaison with its sister global organisation ASOP Global and also other non-profit organisations, such NABP and Fight the Fakes, to effect the best collaboration to support each other's goals.
In 2021/2/3, ASOP EU has been campaigning to ensure the Digital Services Act and NIS2 covers the appropriate areas of the Internet, especially all Intermediaries and to ensure transparency of any business entity (by the provision of genuine and proven contact details). More recently ASOP EU has been campaigning for prescription medicines to be obtained online. Currently 8 Member States have allowed this for many years. A recent report carried out (Q4 2023) by an independent company - Copenhagen Economics amogst 5 Member Sates (n=5000) provided concrete evidence of the benefits especially to the chronically ill in terms of convenience and in term of convenience (time saving amongst other criteria) as well as enhance adherence to treatment regimens.Address
Head Office
London Road, 1386
Leigh on Sea SS9 2UJ
UNITED KINGDOMEU Office
20 Madeira Park
Tunbridge Wells tn2 5sx
UNITED KINGDOMWebsite
-
People
Total lobbyists declared
1
Employment time Lobbyists 50% 1 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
The ASOP EU coalition implements a series of activities with its supporters, members and observers with a major focus on raising public awareness, catalysing voluntary sector actions and campaigning for improvements to policy and legislation. Members participate through teleconferencing and key face to face meetings in close liaison with its ASOP Global counterpart with whom it has a MOU. This is a vital area of activity to protect patients from the rising tide of falsified / counterfeit medicines across Europe and the world. We would urge you to join this important patient safety initiative.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
https://www.euhealthcoalition.eu/
www.kybc.eu
https://nabp.pharmacy/programs/dotpharmacy/#:~:text=NABP%20reviews%20pharmacies%20with%20an,to%20the%20verified%20websites%20list.
https://www.euipo.europa.eu/en/observatory
https://www.coe.int/en/web/medicrime/plenary-meeting
www.onhomealliance.pharmacyMember organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
191,458€
Major funding types in closed year
Grants, Member's contributions
Major contributions in closed year
Type Name Amount Contribution Amazon Core Europe SARL 157,541€ Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
Artificial intelligence and digital
Communication activities
The organisation has completed in 2018 a comprehensive educational campaign via the use of Search engine "adwords" via a Google AdWord Grant which can help the patient and consumer find educational information that will help them to buy their medicines online (where it is legal to do so) more safely. In 2023 ASOP EU will further its involvement with public facing campaigns by collaborating with Member States agencies responsible for the administration and oversight of the Common Logo to support the initiation of public facing campaigns to educate the public on falsified medicines. A survey amongst 12 Member States was completed and many were in agreement to collaborate further and share good practices. In 2019 the ASOP EU was acknowledged as a contributor to a significant OECD/EUIPO report Illicit Trade - Trade in Pharmaceutical Products https://euipo.europa.eu/ohimportal/en/web/observatory/trade-in-counterfeit-pharmaceutical-products. ASOP EU is an active supporter and member of the Advisory group of the NABP top level domain .pharmacy https://nabp.pharmacy/programs/dotpharmacy/#:~:text=NABP%20reviews%20pharmacies%20with%20an,to%20the%20verified%20websites%20list. In 2021 ASOP EU received official "Observer" status of the MediCrime Convention - The Committee of the Parties and has been contributing to the development of this international convention by submitting activities that will potentially enhance the effectiveness of the MediCrime Convention. These were presented in Strasbourg in Q3 2023, in a Plenary session where three activities were recommended 1. Alignment with the DSA 2. Market research to track and monitor progress of any in-country anti-counterfeiting initiatives 3. the adoption of a Top level Domain Name such as the NABP DotPharmacy suffix. ASOP EU has been campaigning to extend the scope of the Digital Services Act and to establish the KYBC principles for all intermediaries and has written letters to the EU parliament/Council and the Commission https://www.kybc.eu/media-positions/#open-letters. In addition it has contributed to the policy inputs on the NIS2 and will support at a country level to ensure that the transposition is as robust as possible. ASOP EU is now following the implementation of the DSA and supporting where it can with DG CONNECT. ASOP EU are Civil Society members of the EUIPO Observatory and has contributed to the Expert groups namely, Domain Names and more recently on the Search Engine work stream. ASOP EU was invited to join the KYBC UK Community and to support this with a patient safety evidence and to help build a healthcare KYBC UK community. ASOP EU is also championing the potential instrument that would, using a Google algorithm, identify and then demote websites selling illicit medicines to low search engine pages. ASOP EU will be holding a EU Parliament meeting on 12th February 2024 hosted by MEP Stelios Kympouropoulos the title of which is "The EU Pharmaceutical legislation - why should online access to prescription medicines be allowed?" within the framework of the Revision of the GPL.
Other activities
None declared
Meetings
Meetings
6 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 21 Nov 2023 Location Online Subject Exchange of views with the Alliance for Safe Online Pharmacy and the European Association of e-Pharmacies on the access to medicines in the context of the pharma reform. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
Other Lobbyists -
Date 08 Apr 2021 Location online Subject Health Union Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Catherine Sustek (Cabinet member)
- Margaritis Schinas (Vice-President)
Other Lobbyists -
Date 22 May 2018 Location Brussels Subject activities and work on patient safety, with particular focus on falsified medicines and the meaning of the Common Logo on legal online pharmacies; top level domain name .pharmacy Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Attending - Eric Peters (Cabinet member)
-
Date 03 May 2018 Location Brussels Subject Falsified medicines Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)
-
Date 04 Mar 2015 Location Brussels Subject Online pharmacies Cabinet Cabinet of Vice-President Andrus Ansip Portfolio Digital Single Market Attending - Jasmin Battista (Cabinet member)
-
Date 02 Mar 2015 Location Brussels Subject Implementation of common logo for online pharmacies Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)